Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial ; volume:19 ; number:1 ; day:11 ; month:7 ; year:2018 ; pages:1-8 ; date:12.2018
BMC nephrology ; 19, Heft 1 (11.7.2018), 1-8, 12.2018
- Urheber
-
Sedhain, Arun
- Beteiligte Personen und Organisationen
-
Hada, Rajani
Agrawal, Rajendra K.
Bhattarai, Gandhi R.
Baral, Anil
SpringerLink (Online service)
- DOI
-
10.1186/s12882-018-0973-7
- URN
-
urn:nbn:de:101:1-2018091922295038464497
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek.
Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sedhain, Arun
- Hada, Rajani
- Agrawal, Rajendra K.
- Bhattarai, Gandhi R.
- Baral, Anil
- SpringerLink (Online service)
Ähnliche Objekte (12)
The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study
Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study
Comparative Efficacy and Safety of Tacrolimus, Cyclosporin A, Mycophenolate Mofetil, Cyclophosphamide, and Corticosteroids as Induction Therapy for Membranous Lupus Nephritis: A Network Meta-Analysis
Effect of tacrolimus with mycophenolate mofetil or cyclophosphamide on the renal response in systemic lupus erythematosus patients
Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus
Efficacy and safety of oral cyclophosphamide versus mycophenolate mofetil in childhood nephrotic syndrome: an open-label comparative study
Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis
Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis
The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study
Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study
Comparative Efficacy and Safety of Tacrolimus, Cyclosporin A, Mycophenolate Mofetil, Cyclophosphamide, and Corticosteroids as Induction Therapy for Membranous Lupus Nephritis: A Network Meta-Analysis
Effect of tacrolimus with mycophenolate mofetil or cyclophosphamide on the renal response in systemic lupus erythematosus patients
Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus
Efficacy and safety of oral cyclophosphamide versus mycophenolate mofetil in childhood nephrotic syndrome: an open-label comparative study
Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis
Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis
The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study
Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study
Comparative Efficacy and Safety of Tacrolimus, Cyclosporin A, Mycophenolate Mofetil, Cyclophosphamide, and Corticosteroids as Induction Therapy for Membranous Lupus Nephritis: A Network Meta-Analysis
Effect of tacrolimus with mycophenolate mofetil or cyclophosphamide on the renal response in systemic lupus erythematosus patients
Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus
Efficacy and safety of oral cyclophosphamide versus mycophenolate mofetil in childhood nephrotic syndrome: an open-label comparative study
Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis
Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma